FDA Inspection 1200804 — CSL Plasma Inc.
The FDA completed an inspection of CSL Plasma Inc. on March 2, 2023 in Harlingen, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 2, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Harlingen, TX (United States)